Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
|Articles|April 15, 2008
The American Journal of Managed Care
- April 2008
- Volume 14
- Issue 4
Strand V, Singh JA. (Am J Manag Care. 2007;13[suppl 9]:S237-S251)
Advertisement
After the publication of our December 2007 supplement, “Health-related Quality of Life in Rheumatoid Arthritis,” the Editors learned that several authors were not given the opportunity to review the final proofs of their manuscripts. As a result, errors were subsequently identified. Due to the extent of the errors in the article by Strand et al, “Improved Health-related Quality of Life With Effective Disease-modifying Antirheumatic Drugs: Evidence From Randomized Controlled Trials,” we have printed the corrected article in our April issue.
to see a corrected version of this article.
Articles in this issue
over 18 years ago
Furst DE, Khanna D. (Am J Manag Care. 2007;13[suppl 9]:S216-S217.over 18 years ago
Strand V, Singh JA. (Am J Manag Care. 2007;[suppl 9]:S237-S251.over 18 years ago
Furst, DE; Khanna, D. (Am J Manag Care. 2007;13[suppl 9]:S216-S217)over 18 years ago
Association of Insurance Coverage With Chlamydia ScreeningAdvertisement
Related to this article
Machine learning prediction of procalcitonin positivity using inexpensive routine laboratory tests may reduce procalcitonin test volume and support diagnostic stewardship.
After Pennsylvania began rewarding Medicaid managed care plans for increasing well-child visits among Black infants, rates did not change significantly overall but varied by region.
Greater 340B activity—measured by county-level hospital child sites and contract pharmacy arrangements—was associated with significantly higher county-level total and out-of-pocket health care spending.
The associate editor of Evidence-Based Oncology says the turnover that will follow this week's midterm election calls for renewed engagement from community oncology leaders with members of Congress, due to pressing reimbursement issues.
Medigap Plan F enrollment has declined since it was closed to new beneficiaries in 2020. The percentage of individual Medigap enrollees relative to non–dually eligible traditional Medicare beneficiaries increased from 2013-2024.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Asundexian, First FXIa Inhibitor to Prevent Repeat Stroke
2
How Plans, Clinicians Should Handle Gray-Market Retatrutide
3
IVF Beats IUI for Early Live Births in Unexplained Infertility
4
Phase 3 Data Back ALP Normalization as Treatment Goal in PBC
5